@xconomy.com 5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com 5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@techcrunch.com 5 years ago
Biotech AI startup Sight Diagnostics gets $27.8M to speed up blood tests
@xconomy.com 5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com 5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com 5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@techcrunch.com 5 years ago
Healthcare wearables level up with new moves from Apple and Alphabet
@xconomy.com 5 years ago
Magnolia Medical Captures $20M to Reduce Blood Culture Contamination
@xconomy.com 5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com 5 years ago
Sentinel Healthcare Raises $2M For Hypertension-Monitoring Software
@xconomy.com 5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com 5 years ago
DermaClip Ramps Up for U.S. Sales Push of Wound-Healing Device
@xconomy.com 5 years ago
After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals
@xconomy.com 5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com 5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com 5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com 5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@engadget.com 5 years ago
FDA approves app-connected digital inhaler
@xconomy.com 5 years ago
San Antonio Seeks to Be Known as Silicon Valley of Military Medicine
@xconomy.com 5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com 5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com 5 years ago
After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield
@xconomy.com 5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com 5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@techcrunch.com 5 years ago
How the Apple Watch changed the world
@xconomy.com 5 years ago
MR3 Health Takes Aim at Foot Ulcers as San Antonio Tackles Diabetes
@xconomy.com 5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com 5 years ago
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech
@xconomy.com 5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com 5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com 5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com 5 years ago
InCube, VelocityTX Join Work to Develop Pediatric Medical Devices
@engadget.com 5 years ago
FDA approves over-the-counter hearing aid from Bose
@xconomy.com 5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com 5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com 5 years ago
Somna Rebrands Acid Reflux Band in Bid to Reach More Patients
@xconomy.com 5 years ago
NorthStar Names Merrick CEO, Appoints Hendricks as Board Chair
@techcrunch.com 5 years ago
Not to be overshadowed by the Apple Watch, AliveCor announces a new 6-lead ECG reader
@techcrunch.com 5 years ago
Natural Cycles contraception app told to clarify pregnancy risks
@xconomy.com 5 years ago
San Antonio Startup Making Noise-Reducing Tech for Babies Adds $1.3M
@engadget.com 5 years ago
E-cig makers have 60 days to show they aren’t targeting minors
@xconomy.com 5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@techcrunch.com 5 years ago
Contraception app Natural Cycles’ Facebook ad banned for being misleading
@xconomy.com 5 years ago
San Antonio’s Spinal Stabilization Technologies Snags $11M Funding
@xconomy.com 5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
@xconomy.com 5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@engadget.com 5 years ago
FDA approves contraceptive app Natural Cycles
@xconomy.com 5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More